annual CFF:
$14.44M+$9.01M(+165.82%)Summary
- As of today (June 1, 2025), AGIO annual cash flow from financing activities is $14.44 million, with the most recent change of +$9.01 million (+165.82%) on December 31, 2024.
- During the last 3 years, AGIO annual CFF has risen by +$780.21 million (+101.89%).
- AGIO annual CFF is now -97.36% below its all-time high of $546.02 million, reached on December 31, 2018.
Performance
AGIO Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.62M-$3.22M(-66.56%)Summary
- As of today (June 1, 2025), AGIO quarterly cash flow from financing activities is $1.62 million, with the most recent change of -$3.22 million (-66.56%) on March 31, 2025.
- Over the past year, AGIO quarterly CFF has dropped by -$4.25 million (-72.39%).
- AGIO quarterly CFF is now -99.69% below its all-time high of $528.28 million, reached on March 31, 2018.
Performance
AGIO quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$10.20M-$4.25M(-29.39%)Summary
- As of today (June 1, 2025), AGIO TTM cash flow from financing activities is $10.20 million, with the most recent change of -$4.25 million (-29.39%) on March 31, 2025.
- Over the past year, AGIO TTM CFF has increased by +$1.37 million (+15.48%).
- AGIO TTM CFF is now -98.74% below its all-time high of $809.34 million, reached on March 31, 2018.
Performance
AGIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AGIO Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +165.8% | -72.4% | +15.5% |
| 3 y3 years | +101.9% | +34.0% | +101.3% |
| 5 y5 years | -95.0% | -69.9% | -96.5% |
AGIO Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.9% | -72.4% | +2516.4% | -29.4% | +101.3% |
| 5 y | 5-year | -95.0% | +101.9% | -99.4% | +100.3% | -98.1% | +101.3% |
| alltime | all time | -97.4% | +101.9% | -99.7% | +100.3% | -98.7% | +101.3% |
AGIO Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $1.62M(-66.6%) | $10.20M(-29.4%) |
| Dec 2024 | $14.44M(+165.8%) | $4.84M(+83.6%) | $14.44M(+38.2%) |
| Sep 2024 | - | $2.64M(+139.9%) | $10.45M(+7.8%) |
| Jun 2024 | - | $1.10M(-81.3%) | $9.69M(+9.8%) |
| Mar 2024 | - | $5.86M(+592.3%) | $8.83M(+62.5%) |
| Dec 2023 | $5.43M(+131.2%) | $847.00K(-55.0%) | $5.43M(+17.9%) |
| Sep 2023 | - | $1.88M(+694.1%) | $4.61M(+17.8%) |
| Jun 2023 | - | $237.00K(-90.4%) | $3.91M(+8.4%) |
| Mar 2023 | - | $2.47M(>+9900.0%) | $3.61M(+53.6%) |
| Dec 2022 | $2.35M(-100.3%) | $22.00K(-98.1%) | $2.35M(-114.5%) |
| Sep 2022 | - | $1.19M(-1871.6%) | -$16.26M(-93.9%) |
| Jun 2022 | - | -$67.00K(-105.5%) | -$268.43M(-65.2%) |
| Mar 2022 | - | $1.21M(-106.5%) | -$771.82M(+0.8%) |
| Dec 2021 | -$765.77M(-392.8%) | -$18.59M(-92.6%) | -$765.77M(+2.6%) |
| Sep 2021 | - | -$250.99M(-50.1%) | -$746.60M(+51.7%) |
| Jun 2021 | - | -$503.46M(-7033.7%) | -$492.17M(-286.9%) |
| Mar 2021 | - | $7.26M(+1147.6%) | $263.39M(+0.7%) |
| Dec 2020 | $261.52M(-9.7%) | $582.00K(-83.1%) | $261.52M(-51.4%) |
| Sep 2020 | - | $3.45M(-98.6%) | $538.54M(+0.0%) |
| Jun 2020 | - | $252.10M(+4581.6%) | $538.43M(+85.6%) |
| Mar 2020 | - | $5.38M(-98.1%) | $290.14M(+0.2%) |
| Dec 2019 | $289.61M(-47.0%) | $277.61M(+8219.0%) | $289.61M(+2124.2%) |
| Sep 2019 | - | $3.34M(-12.4%) | $13.02M(-23.0%) |
| Jun 2019 | - | $3.81M(-21.6%) | $16.91M(-25.2%) |
| Mar 2019 | - | $4.86M(+378.3%) | $22.61M(-95.9%) |
| Dec 2018 | $546.02M | $1.02M(-85.9%) | $546.02M(-0.3%) |
| Sep 2018 | - | $7.22M(-24.0%) | $547.60M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $9.51M(-98.2%) | $545.70M(-32.6%) |
| Mar 2018 | - | $528.28M(>+9900.0%) | $809.34M(+183.9%) |
| Dec 2017 | $285.11M(+67.9%) | $2.59M(-51.4%) | $285.11M(-0.5%) |
| Sep 2017 | - | $5.32M(-98.1%) | $286.51M(-35.5%) |
| Jun 2017 | - | $273.15M(+6651.2%) | $444.42M(+157.3%) |
| Mar 2017 | - | $4.05M(+1.3%) | $172.72M(+1.7%) |
| Dec 2016 | $169.78M(+2564.0%) | $3.99M(-97.6%) | $169.78M(+1.6%) |
| Sep 2016 | - | $163.23M(>+9900.0%) | $167.07M(+2676.7%) |
| Jun 2016 | - | $1.45M(+30.8%) | $6.02M(+6.3%) |
| Mar 2016 | - | $1.11M(-13.9%) | $5.66M(-11.2%) |
| Dec 2015 | $6.37M(-98.1%) | $1.29M(-40.8%) | $6.37M(-97.4%) |
| Sep 2015 | - | $2.17M(+99.2%) | $244.15M(+0.7%) |
| Jun 2015 | - | $1.09M(-40.1%) | $242.34M(-28.0%) |
| Mar 2015 | - | $1.82M(-99.2%) | $336.40M(+0.4%) |
| Dec 2014 | $335.16M(+170.6%) | $239.06M(>+9900.0%) | $335.16M(+250.3%) |
| Sep 2014 | - | $367.00K(-99.6%) | $95.68M(-56.4%) |
| Jun 2014 | - | $95.15M(>+9900.0%) | $219.54M(+76.4%) |
| Mar 2014 | - | $582.00K(-237.3%) | $124.44M(+0.4%) |
| Dec 2013 | $123.88M(>+9900.0%) | -$424.00K(-100.3%) | $123.88M(-0.4%) |
| Sep 2013 | - | $124.23M(>+9900.0%) | $124.36M(>+9900.0%) |
| Jun 2013 | - | $47.00K(+88.0%) | $160.00K(+24.0%) |
| Mar 2013 | - | $25.00K(-53.7%) | $129.00K(-9.2%) |
| Dec 2012 | $142.00K(-99.8%) | $54.00K(+58.8%) | $142.00K(+61.4%) |
| Sep 2012 | - | $34.00K(+112.5%) | $88.00K(+63.0%) |
| Jun 2012 | - | $16.00K(-57.9%) | $54.00K(+42.1%) |
| Mar 2012 | - | $38.00K | $38.00K |
| Dec 2011 | $77.36M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CFF year-on-year change?
- What is Agios Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFF year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFF year-on-year change?
What is Agios Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AGIO is $14.44M
What is the all time high annual CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from financing activities is $546.02M
What is Agios Pharmaceuticals annual CFF year-on-year change?
Over the past year, AGIO annual cash flow from financing activities has changed by +$9.01M (+165.82%)
What is Agios Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AGIO is $1.62M
What is the all time high quarterly CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from financing activities is $528.28M
What is Agios Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AGIO quarterly cash flow from financing activities has changed by -$4.25M (-72.39%)
What is Agios Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AGIO is $10.20M
What is the all time high TTM CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from financing activities is $809.34M
What is Agios Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AGIO TTM cash flow from financing activities has changed by +$1.37M (+15.48%)